HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

András Gruber Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2019Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


András Gruber Research Topics

Disease

22Thrombosis (Thrombus)
01/2021 - 07/2002
9Hemorrhage
06/2020 - 01/2007
8Sepsis (Septicemia)
01/2021 - 01/2008
7Inflammation (Inflammations)
01/2021 - 07/2011
4Stroke (Strokes)
01/2021 - 06/2010
3Neoplasms (Cancer)
10/2019 - 06/2013
2Myocardial Infarction
01/2021 - 06/2010
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 02/2015
2Leukemia
10/2019 - 10/2013
2Neoplasm Metastasis (Metastasis)
10/2019 - 11/2013
2Reperfusion Injury
01/2018 - 09/2012
2Polyps
01/2018 - 01/2017
2Vascular System Injuries
01/2017 - 12/2016
2Ischemic Stroke
09/2012 - 06/2011
2Cerebral Infarction
09/2012 - 06/2011
1Anemia
12/2021
1Chronic Kidney Failure (Chronic Renal Failure)
12/2021
1Fever (Fevers)
01/2021
1Hypotension (Low Blood Pressure)
01/2021
1Multiple Sclerosis
01/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2021
1Atherosclerosis
01/2021
1Breast Neoplasms (Breast Cancer)
10/2019
1Pathologic Processes
10/2019
1Staphylococcal Infections
01/2019
1Infections
01/2019
1Septic Shock (Toxic Shock Syndrome)
01/2019
1Venous Thromboembolism
01/2019
1Bacteremia
01/2019
1Colonic Neoplasms (Colon Cancer)
01/2019
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2018
1Bruton type agammaglobulinemia
03/2016
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2016
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2016
1Demyelinating Diseases (Demyelinating Disease)
02/2015

Drug/Important Bio-Agent (IBA)

13ThrombinFDA Link
12/2021 - 01/2009
11Factor XI (Plasma Thromboplastin Antecedent)IBA
12/2021 - 07/2008
9FibrinIBA
01/2019 - 01/2007
8Thromboplastin (Tissue Factor)IBA
06/2020 - 11/2010
5Hemostatics (Antihemorrhagics)IBA
06/2020 - 01/2007
5Protein CIBA
01/2020 - 05/2007
4Blood Coagulation Factors (Coagulation Factor)IBA
01/2021 - 06/2013
4CollagenIBA
01/2018 - 01/2009
4Factor XII (Hageman Factor)IBA
09/2012 - 01/2009
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019 - 01/2009
3AnticoagulantsIBA
05/2012 - 01/2007
2AB023IBA
12/2021 - 01/2019
2Biomarkers (Surrogate Marker)IBA
01/2021 - 10/2013
2Peroxidase (Myeloperoxidase)IBA
01/2021 - 01/2017
2PrekallikreinIBA
01/2021 - 05/2012
2EnzymesIBA
01/2020 - 05/2007
2Proteins (Proteins, Gene)FDA Link
01/2019 - 03/2016
2PolyphosphatesIBA
01/2018 - 01/2017
2cancer procoagulantIBA
10/2017 - 10/2013
2Prothrombin (Factor II)IBA
01/2017 - 01/2007
2Fibrinolytic Agents (Antithrombotic Agents)IBA
11/2013 - 01/2009
2Factor IX (Coagulation Factor IX)FDA LinkGeneric
06/2013 - 11/2010
2Clopidogrel (Plavix)FDA Link
07/2012 - 06/2010
2Factor VIIa (Activated Factor VII)IBA
11/2010 - 01/2007
1ErythropoietinFDA Link
12/2021
1Heparin (Liquaemin)FDA LinkGeneric
12/2021
1IronIBA
12/2021
1Complement System Proteins (Complement)IBA
01/2021
1cadherin 5IBA
01/2021
1ISIS 416858IBA
01/2021
1AntibodiesIBA
01/2021
1InterleukinsIBA
01/2021
1Kininogens (Kininogen)IBA
01/2021
1Nucleosomes (Nucleosome)IBA
01/2021
1LDL Receptors (LDL Receptor)IBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2021
1Interleukin-8 (Interleukin 8)IBA
01/2021
1Interleukin-10 (Interleukin 10)IBA
01/2021
14,5,6,7- tetrahydroisoxazolo(4,5- c)pyridin- 3- ol (THPO)IBA
10/2019
1Platelet Factor 4IBA
10/2019
1Thrombopoietin (c-mpl Ligand)IBA
10/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2019
1Pharmaceutical PreparationsIBA
01/2019
1Purinergic P2Y Receptor AntagonistsIBA
01/2019
1protease-activated receptor 4IBA
01/2019
1Adenosine Diphosphate (ADP)IBA
01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1Thromboxane A2 (A2, Thromboxane)IBA
01/2019
1P-SelectinIBA
01/2018
1Fibrinogen (Factor I)FDA Link
01/2018
1von Willebrand FactorIBA
01/2017
1Ellagic AcidIBA
01/2017
1Endothelial Protein C ReceptorIBA
01/2017
1Blocking AntibodiesIBA
03/2016
1Phospholipases (Phospholipase)IBA
03/2016
1platelet membrane glycoprotein VIIBA
03/2016
1ibrutinibIBA
03/2016
1estropipate (Ogen)FDA LinkGeneric
02/2015

Therapy/Procedure

6Therapeutics
01/2021 - 01/2007
2Lasers (Laser)
06/2011 - 11/2010
1Renal Dialysis (Hemodialysis)
12/2021
1Euthanasia (Mercy Killing)
10/2019